﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>8</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2018</Year>
        <Month>01</Month>
        <DAY>20</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Chemiluminescence based immunoassay for the detection of heroin and its metabolites</ArticleTitle>
    <FirstPage>53</FirstPage>
    <LastPage>58</LastPage>
    <ELocationID EIdType="doi">10.15171/bi.2018.07</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Smritee</FirstName>
        <LastName>Singh</LastName>
      </Author>
      <Author>
        <FirstName>Priya</FirstName>
        <LastName>Mishra</LastName>
      </Author>
      <Author>
        <FirstName>Ivneet</FirstName>
        <LastName>Banga</LastName>
      </Author>
      <Author>
        <FirstName>Avanish S</FirstName>
        <LastName>Parmar</LastName>
      </Author>
      <Author>
        <FirstName>Prem Prakash</FirstName>
        <LastName>Tripathi</LastName>
      </Author>
      <Author>
        <FirstName>Sonu</FirstName>
        <LastName>Gandhi</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/bi.2018.07</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>03</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>10</Month>
        <Day>22</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Continuous use of opiates causes drug-related illnesses, which poses an alarming situation to develop sensitive detection platform. In this study, a highly sensitive and reliable chemiluminescence immunoassay (CI) has been developed for the detection of heroin and its major metabolites in spiked urine samples. Methods: To develop robust immunoassay, monoacetyl morphine-bovine serum albumin (MAM-BSA) conjugate was synthesized and characterized thoroughly by physicochemical techniques. The anti-MAM antibodies were developed, labeled with horseradish peroxidase (HRP) and immunoassay was developed to detect the presence of target drug in spiked urine samples. Results: A competitive CI was developed, where heroin, MAM, morphine, and codeine concentration were ranged from 0-1000 ng/ mL in spiked urine samples and limit of detection were 80, 95, 90, 75 pg/ mL. Conclusion: The developed CI is highly sensitive, specific, point of care, cost-effective and can be used as a routine technique for quantitative analysis for screening of narcotic drugs.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Monoacetyl morphine</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Metabolites</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chemiluminescence immunoassay</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Antibody</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Horseradish peroxidase</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>